Loss of the putative RNA-directed RNA polymerase RRF-3 makes C. elegans hypersensitive to RNAi.
By F. Simmer, M. Tijsterman, S. Parrish, S. Koushika, M. Nonet, Andrew Fire, J. Ahringer, Ronald H. A. Plasterk. Current Biology, 2002
640 citations recorded by the source corpus.
RNA interference (RNAi) is a broadly used reverse genetics method in C. elegans. Unfortunately, RNAi does not inhibit all genes. We show that loss of function of a putative RNA-directed RNA polymerase (RdRP) of C. elegans, RRF-3, results in a substantial enhancement of sensitivity to RNAi in diverse tissues. This is particularly striking in the nervous system; neurons that are generally refractory to RNAi in a wild-type genetic background can respond effectively to interference in an rrf-3 mutant background. These data provide the first indication of physiological negative modulation of the RNAi response and implicate an RdRP-related factor in this effect. The rrf-3 strain can be useful to study genes that, in wild-type, do not show a phenotype after RNAi, and it is probably the strain of choice for genome-wide RNAi screens.
Subfields: Aging, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/940d66a1fdc725341743ad91e6e860f87fdea517
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Aging
- Ronald H. A. Plasterk
- J. Ahringer
- F. Simmer
- R. Kamath
- Andrew G. Fraser
- T. Blackwell
- Gary Ruvkun
- James C. Carrington
In Molecular Biology
- J. Ahringer
- R. Poethig
- Elisabeth J. Chapman
- R. Kamath
- Gang Wu
- James C. Carrington
- Andrew G. Fraser
- M. Yoshikawa
Citations in the corpus
- Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. (2005, methodology): “The RNAi hypersensitive strain rrf-3 ( Simmer et al., 2002 ) was used for feeding RNAi experiments targeting xrn-1 or Y48B6A.3.”
- Guidelines on nicotine dose selection for in vivo research (2007, background): “While neurons have generally proven resistant to RNAi, new hypersensitive strains, such as the RNA-directed RNA polymerase mutant rrf-3, appear to overcome this problem (Simmer et al. 2002).”
- Mechanisms of gene silencing by double-stranded RNA (2004, neutral): “The presumably inactive RdRP-family protein RRF-3 (ref”
- Caenorhabditis elegans: An Emerging Model in Biomedical and Environmental Toxicology (2008, background): “Strategies to improve RNAi efficiency, especially in neurons, were further developed (Esposito et al., 2007; Lee et al., 2006; Simmer et al. 2002, 2003; Tabara et al., 2002; Tops et al., 2005).”
- Specialization and evolution of endogenous small RNA pathways (2007, background): “elegans mutants with an enhanced RNAi response ( eri mutants”
- Genome-Wide RNAi of C. elegans Using the Hypersensitive rrf-3 Strain Reveals Novel Gene Functions (2003, background): “A more detailed study of RNAi sensitivity of rrf-3 mutants using a set of 80 genes showed that rrf-3 is generally more sensitive to RNAi than wild-type worms (Simmer et al. 2002).”
- SGS3 and SGS2/SDE1/RDR6 are required for juvenile development and the production of trans-acting siRNAs in Arabidopsis. (2004, background): “RdRPs that participate in PTGS/RNAi have also been described in Caenorhabditis elegans (Smardon et al. 2000; Sijen et al. 2001; Simmer et al. 2002), Neurospora crassa (Cogoni and Macino 1999; Catalanotto et al. 2002; Shiu and Metzenberg 2002), Schizosaccharomyces pombe (Volpe et al. 2002, 2003) and…”
- Direct inhibition of the longevity-promoting factor SKN-1 by insulin-like signaling in C. elegans. (2008, positive): “(E) In the RNAi-sensitive rrf-3 background (Simmer et al., 2002), the life-span increase seen in daf-2(e1368) is comparably suppressed by either skn-1 or skn-1a/c RNAi.”
- A conserved siRNA-degrading RNase negatively regulates RNA interference in C. elegans (2004, background): “elegans , the RNA-dependent RNA polymerase encoded by rrf-3 , shows identical pleiotropic phenotypes, suggesting that even these limited pleiotropies are probably a consequence of a defect in the siRNase (or possibly microRNase) function of ERI-1 and not in the processing of unrelated cellular mRNA”